Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sean, Bentley"'
Autor:
Hewa Artin, Sean Bentley, Eamonn Mehaffey, Fred X. Liu, Kevin Sojourner, Andrew W. Bismark, David Printz, Ellen E. Lee, Brian Martis, Sharon De Peralta, Dewleen G. Baker, Jyoti Mishra, Dhakshin Ramanathan
Publikováno v:
EClinicalMedicine, Vol 48, Iss , Pp 101439- (2022)
Summary: Background: (S)-ketamine is a glutamatergic drug with potent and rapid acting effects for the treatment of depression. Little is known about the effectiveness of intranasal (S)-ketamine for treating patients with comorbid depression and post
Externí odkaz:
https://doaj.org/article/242ecd618d914a6eae1532cfd7779b8a
Autor:
Sean Bentley
Publikováno v:
IEEE Women in Engineering Magazine. 17:28-31
Autor:
Sean Bentley, Hewa Artin, Eamonn Mehaffey, Fred Liu, Kevin Sojourner, Andrew Bismark, David Printz, Ellen E. Lee, Brian Martis, Sharon De Peralta, Dewleen G. Baker, Jyoti Mishra, Dhakshin Ramanathan
Publikováno v:
Pharmacotherapy, vol 42, iss 3
BackgroundRacemic (R,S)-ketamine is a glutamatergic drug with potent and rapid acting antidepressant effects. An intranasal formulation of (S)-ketamine was recently approved by the US Food and Drug Administration (FDA) to be used in individuals with
Publikováno v:
International Journal of Environmental Research and Public Health
Volume 18
Issue 22
International Journal of Environmental Research and Public Health, Vol 18, Iss 11923, p 11923 (2021)
Volume 18
Issue 22
International Journal of Environmental Research and Public Health, Vol 18, Iss 11923, p 11923 (2021)
The prevalence of tobacco use increases in times of stress
however, during the initial stage of the COVID-19 pandemic, tobacco use rates stayed the same in most populations. Previous work focused on the initial months of the pandemic, while this
however, during the initial stage of the COVID-19 pandemic, tobacco use rates stayed the same in most populations. Previous work focused on the initial months of the pandemic, while this
Autor:
Hewa, Artin, Sean, Bentley, Eamonn, Mehaffey, Fred X, Liu, Kevin, Sojourner, Andrew W, Bismark, David, Printz, Ellen E, Lee, Brian, Martis, Sharon, De Peralta, Dewleen G, Baker, Jyoti, Mishra, Dhakshin, Ramanathan
Publikováno v:
EClinicalMedicine. 48
(We performed a retrospective case series analysis of clinical outcomes in 35 Veterans with co-morbid depression and PTSD who were treated with intranasal (During the induction phase of treatment there was an absolute reduction of 5.1 (SEM 0.7) on th
Autor:
Dhakshin S. Ramanathan, Hewa Artin, Sean Bentley, Fred X. Liu, David Printz, Jyoti Mishra, Sharon De Peralta, Brian Martis, Dewleen G. Baker, Kevin Sojourner, Andrew W. Bismark, Eamonn Mehaffey, Ellen E. Lee
Publikováno v:
SSRN Electronic Journal.
Objective: Ketamine is a glutamatergic drug with potent and rapid acting effects for the treatment of depression. Little is known about the effectiveness of intranasal (S)-ketamine for treating patients with comorbid depression and PTSD. Methods: We